Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma

Journal of Cutaneous Pathology

Volumn 39, Issue 12, 2012, Pages 1062-1074

  Mason, Ashley ^a   Wititsuwannakul, Jade ^a,b   Klump, Vincent R ^a   Lott, Jason ^a   Lazova, Rossitza ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

immunohistochemistry; melanocytic neoplasms; melanoma; p16 protein

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL COUNT; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; METABOLISM; METHODOLOGY; MIDDLE AGED; NEVUS; PRESCHOOL CHILD; PROGNOSIS; SKIN TUMOR; SURVIVAL RATE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEVUS, EPITHELIOID AND SPINDLE CELL; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84870242952     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12014     Document Type: Article

References (43)

1. Barnhill RL,. The spitzoid lesion: rethinking Spitz tumors, atypical variants, 'spitzoid melanoma' and risk assessment. Mod Pathol 2006; 19 (Suppl. 2): S21.
2. Barnhill RL, Cerroni L, Cook M, et al. State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Adv Anat Pathol 2010; 17: 73.
3. Li LX, Crotty KA, McCarthy SW, Palmer AA, Kril JJ,. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol 2000; 22: 489.
4. Kanter-Lewensohn L, Hedblad MA, Wejde J, Larsson O,. Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. Mod Pathol 1997; 10: 917.
5. Harvell JD, Bastian BC, LeBoit PE,. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases. Am J Surg Pathol 2002; 26: 654.
6. Bergman R, Dromi R, Trau H, Cohen I, Lichtig C,. The pattern of HMB-45 antibody staining in compound Spitz nevi. Am J Dermatopathol 1995; 17: 542.
7. King MS, Porchia SJ, Hiatt KM,. Differentiating spitzoid melanomas from Spitz nevi through CD99 expression. J Cutan Pathol 2007; 34: 576.
8. Ribé A, McNutt NS,. S100A6 protein expression is different in Spitz nevi and melanomas. Mod Pathol 2003; 16: 505.
9. Piepkorn M,. Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors. J Am Acad Dermatol 2000; 42 (5 Pt 1): 705.
10. Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nat Genet 1994; 8: 15.
11. Talve L, Sauroja I, Collan Y, Punnonen K, Ekfors T,. Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage. Int J Cancer 1997; 74: 255.
12. Reed JA, Loganzo F, Shea CR, et al. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 1995; 55: 2713.
13. Funk JO, Schiller PI, Barrett MT, Wong DJ, Kind P, Sander CA,. p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma. J Cutan Pathol 1998; 25: 291.
14. Richmond-Sinclair NM, Lee E, Cummings MC, et al. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas. Melanoma Res 2008; 18: 336.
15. Sparrow LE, Eldon MJ, English DR, Heenan PJ,. p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry. Am J Dermatopathol 1998; 20: 255.
16. Al Dhaybi R, Agoumi M, Gagné I, McCuaig C, Powell J, Kokta V,. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi. J Am Acad Dermatol 2011; 65: 357.
17. Serrano M, Hannon GJ, Beach D,. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704.
18. Sherr CJ, Roberts JM,. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9: 1149.
19. Graña X, Reddy EP,. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995; 11: 211.
20. George E, Polissar NL, Wick M,. Immunohistochemical evaluation of p16INK4A, E-cadherin, and cyclin D1 expression in melanoma and Spitz tumors. Am J Clin Pathol 2010; 133: 370.
21. Hilliard NJ, Krahl D, Sellheyer K,. p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma. J Cutan Pathol 2009; 36: 753.
22. Requena C, Botella R, Nagore E, et al. Characteristics of spitzoid melanoma and clues for differential diagnosis with Spitz nevus. Am J Dermatopathol 2012; 34: 478.
23. Paradela S, Fonseca E, Pita S, et al. spitzoid melanoma in children: clinicopathological study and application of immunohistochemistry as an adjunct diagnostic tool. J Cutan Pathol 2009; 36: 740.
24. Tran SL, Haferkamp S, Scurr LL, et al. Absence of distinguishing senescence traits in human melanocytic nevi. J Invest Dermatol 2012; 132: 2226.
25. Díaz A, Valera A, Carrera C, et al. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies. Am J Surg Pathol 2011; 35: 1733.
26. Hsieh R, Firmiano A, Sotto MN,. Expression of p16 protein in acral lentiginous melanoma. Int J Dermatol 2009; 48: 1303.
27. Wang YL, Uhara H, Yamazaki Y, Nikaido T, Saida T,. Immunohistochemical detection of CDK4 and p16INK4 proteins in cutaneous malignant melanoma. Br J Dermatol 1996; 134: 269.
28. Franchi A, Alos L, Gale N, et al. Expression of p16 in sinonasal malignant melanoma. Virchows Arch 2006; 449: 667.
29. de Andrade BA, Leõn JE, Carlos R, Delgado-Azañero W, Mosqueda-Taylor A, de Almeida OP,. Immunohistochemical expression of p16, p21, p27 and cyclin D1 in oral nevi and melanoma. Head Neck Pathol 2012; 6: 297.
30. Zoroquiain P, Fernandes BF, González S, Novais GN, Schalper KA, Burnier MN,. p16ink4a expression in benign and malignant melanocytic conjunctival lesions. Int J Surg Pathol 2012; 20: 240.
31. Stefanaki C, Stefanaki K, Antoniou C, et al. Cell cycle and apoptosis regulators in Spitz nevi: comparison with melanomas and common nevi. J Am Acad Dermatol 2007; 56: 815.
32. Scurr LL, McKenzie HA, Becker TM, et al. Selective loss of wild-type p16(INK4a) expression in human nevi. J Invest Dermatol 2011; 131: 2329.
33. Reynisdõttir I, Massagué J,. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev 1997; 11: 492.
34. Geradts J, Kratzke RA, Niehans GA, Lincoln CE,. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res 1995; 55: 6006.
35. Mihic-Probst D, Mnich CD, Oberholzer PA, et al. p16 expression in primary malignant melanoma is associated with prognosis and lymph node status. Int J Cancer 2006; 118: 2262.
36. Lewis JS,. p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol 2012; 6 (Suppl. 1): 75.
37. Tozawa-Ono A, Yoshida A, Yokomachi N, et al. Heat shock protein 27 and p16 immunohistochemistry in cervical intraepithelial neoplasia and squamous cell carcinoma. Hum Cell 2012; 25: 24.
38. Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 2009; 35: 210.
39. Gammon B, Beilfuss B, Guitart J, Gerami P,. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe. Am J Surg Pathol 2012; 36: 81.
40. Cerroni L, Barnhill R, Elder D, et al. Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. Am J Surg Pathol 2010; 34: 314.
41. McCalmont TH,. In my opinion. J Cutan Pathol 2011; 38: 268.
42. Gill M, Cohen J, Renwick N, Mones JM, Silvers DN, Celebi JT,. Genetic similarities between Spitz nevus and spitzoid melanoma in children. Cancer 2004; 101: 2636.
43. McCalmont TH,. Fillet of FISH. J Cutan Pathol 2011; 38: 327.